904sek
4,4 %
Date:2025-06-05Time:18:00:00Latest report:Q1-2025List:SpotlightTicker:RESP
Market Cap:46 msekEnterprise Value:41 msekNet Sales:- msekEarnings:-7,81 msekEmployees:0ISIN:SE0023314315

Ratios

10-year key figure history for Respiratorius turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Respiratorius with index and moving average MA50 and MA200.

Stockprice:9,04
MA50:5,70
MA200:6,32
Price/MA200:42,9 %
RSI (14):81,2
Price/MA50:58,5 %

Description

Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer, and especially aggressive lymphoma. The company was originally established in 1999 as a spin-off from Lund University. The business is located in Sweden, where research is conducted in-house but also through international partners. The company is headquartered in Lund.

Biotechnology